Hahn Says COVID Vaccine Review Could Take Months As Trump Floats Rejecting New EUA Guidance

Commissioner’s comments were yet another sign that US FDA won’t clear a vaccine ahead of the election, but hours later the president suggests the White House may decline to clear the agency’s new guidance on emergency use authorization standards for COVID-19 vaccines, raising new concerns about political interference in any decisions.

FDA Commisioner Hahn, NIAID Director Fauci, CDC Director Robert Redfield and HHS's Brett Giroir testify at the Senate HELP Committee on 23 September 2020
FDA Commisioner Hahn, NIAID Director Fauci, CDC Director Robert Redfield and HHS's Brett Giroir testify at the Senate HELP Committee

It typically takes the US Food and Drug Administration weeks to months to review a vaccine application after it is submitted to the agency, Commissioner Stephen Hahn told Senators on 23 September when asked how long it will likely take the agency to reach a decision on a COIVD-19 vaccine once an application is filed.

The admission casts further doubt on the likelihood a COVID-19 vaccine could receive an approval or emergency use authorization before...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet